ETON
Eton Pharmaceuticals Inc
NASDAQ: ETON · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$24.12
+2.29% today
Updated 2026-04-30
Market cap
$628.09M
P/E ratio
—
P/S ratio
7.86x
EPS (TTM)
$-0.17
Dividend yield
—
52W range
$13 – $27
Volume
0.4M
Eton Pharmaceuticals Inc (ETON) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-5.76%
Operating margin
21.00%
ROE
-18.20%
ROA
3.59%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | $0.00 | $-7.16M | — | — | — |
| 2018 | $0.00 | $-12.74M | — | — | — |
| 2019 | $959000.00 | $-18.32M | 52.76% | -1,939.62% | -1,910.32% |
| 2020 | $39000.00 | $-27.97M | -633.33% | -69,515.38% | -71,717.95% |
| 2021 | $21.83M | $-1.96M | 87.99% | -6.85% | -8.95% |
| 2022 | $21.25M | $-9.02M | 67.38% | -38.87% | -42.45% |
| 2023 | $31.64M | $-936000.00 | 66.56% | -3.77% | -2.96% |
| 2024 | $39.01M | $-3.82M | 60.01% | -6.66% | -9.80% |
| 2025 | $79.95M | $-4.60M | 53.46% | 0.09% | -5.75% |